Intraperitoneal Paclitaxel With NALIRIFOX for Pancreatic Ductal Adenocarcinoma With Peritoneal Carcinomatosis

Clinical trial NCT07030283 · RECRUITING

Trial details

NCT number: NCT07030283
Sponsor: University of Colorado, Denver
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Pancreatic Ductal Adenocarcinoma (PDAC)

Start date: 2025-12-31
Primary completion: 2028-07-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.